5 posts
Standard
In a significant advancement for neuroscience, a team of researchers led by Professor Nicholas Barnes at the University of Birmingham has identified a promising new pathway to mitigate harmful inflammation in the brain. The study, published in the journal Brain, focuses on the P2X7 receptor—a protein that acts as a key driver of neuroinflammatory responses.…
Standard
Scientists at the University of Birmingham have unveiled a promising new strategy to combat harmful inflammation in the human brain. By identifying and targeting a specific receptor known as P2X7, researchers believe they have discovered a viable pathway to reduce neuroinflammation—a process that underlies a wide array of devastating neurological and psychiatric conditions. Crucially, the…
Standard
Scientists at the University of Birmingham have unveiled a significant breakthrough in the ongoing battle against neuroinflammation, identifying a specific biological receptor that could pave the way for new, highly effective treatments. The research, published in the journal Brain and led by Professor Nicholas Barnes, points to the P2X7 receptor as a primary driver of…
Standard
Scientists have identified a promising new pathway for reducing neuroinflammation—a chronic, damaging immune response within the brain that is linked to a wide array of devastating neurological and psychiatric conditions. In a study published in the journal Brain, a research team led by Professor Nicholas Barnes at the University of Birmingham has pinpointed the P2X7…
Standard
In a significant stride toward understanding and treating neurodevelopmental conditions, researchers have identified a potential therapeutic pathway for autism spectrum disorder (ASD) by focusing on a specific brain receptor. A study led by Director Eunjoon Kim of the Institute for Basic Science (IBS) Center for Synaptic Brain Dysfunctions has unveiled that modulating a specific glycine…
